Navigating the New Normal in Biotech Policy
Biotech has never been an industry for the faint of heart, but the regulatory environment we are navigating today feels different. The forces shaping our industry, from policy upheaval and institutional erosion to a funding market that rewards the few and starves the many, are converging in ways that demand both attention and action. About our Board … Read more
